ceftazidime

TERMINATED · PHASE4 · Cystic Fibrosis, Pseudomonas Aeruginosa, Pulmonary Exacerbation

Unknown stopping reason

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.